Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A patient who presents for AOD-9604 as a perceived "milder" or "more natural" alternative to approved GLP-1 receptor agonists is still a patient who needs a validated depression screen (PHQ-A for adolescents), an Eating Disorder Examination Questionnaire, and a conversation about body image expectations
research compound only Product Specifications Format: capsules Strength: 50 mg per capsule Count: 60 capsules per bottle Purity: 99% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
Actual dosing is based on individual physician recommendations
If you discontinue semaglutide, expect appetite to begin returning to baseline around week 3 post-discontinuation
&srotate=0)
US$ 22.79
US$ 29.39
US$ 27.93
